Patents for C12R 1 - Micro-organisms (92,025)
10/2000
10/31/2000US6140061 Response regulator
10/31/2000US6140059 Methods for the obtention of human immunodeficiency virsus Type 1 envelope glycoproteins in native and oligomeric form employing recombinant chimeric antigens containing collagenase recognition sites.
10/31/2000US6139846 Protein D- an IGD-binding protein of haemophilus influenzae
10/31/2000CA2185112C Humanized monoclonal antibodies against human interleukin-4
10/31/2000CA2089193C Diacetyl production
10/31/2000CA2025605C Method of purifying human serum albumin
10/31/2000CA1341131C Human nerve growth factor
10/31/2000CA1341130C Use of oxidoreductases in bleaching and/or detergent compositions and their preparation by microorganisms engineered by recombinant dna technology
10/30/2000CA2306732A1 Enhanced growth of lactic acid bacteria in milk
10/27/2000CA2307104A1 Human myoblast cell lines and their uses
10/26/2000WO2000063412A1 HETEROPOLYSACCHARIDE PRODUCED BY $i(PSEUDOMONAS SP)
10/26/2000WO2000063403A2 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein
10/26/2000WO2000063379A2 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
10/26/2000WO2000063355A1 Method for treatment of an aqueous flux by electropulsation of a field parallel to the flow, pulsation chamber and uses thereof
10/26/2000WO2000063348A2 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof
10/26/2000WO2000063345A1 PSEUDOMYCIN PRODUCTION BY $i(PSEUDOMONAS SYRINGAE)
10/26/2000WO2000063245A2 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant
10/26/2000WO2000063240A1 ANTIFUNGAL AGENTS ISOLATED FROM $i(PSEUDOMONAS SYRINGAE)
10/26/2000WO2000063237A2 Pseudomycin analogs
10/26/2000WO2000036135A3 Screening methods based on the use of protein kinases
10/26/2000WO2000035481A3 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation
10/26/2000WO2000034444A3 Method and composition for preserving viruses
10/26/2000WO2000026391A3 Trans-species transfer of apoptotic genes and transgenic plants developed thereby
10/26/2000WO2000024924A3 Methods for screening protease variants for use in detergent compositions
10/26/2000WO2000023806A9 Detection and quantification of vancomycin in biological fluids
10/26/2000DE19857302C2 Verfahren zur enantioselektiven Reduktion von 3,5-Dioxocarbonsäuren, deren Salze und Ester A process for the enantioselective reduction of 3,5-Dioxocarbonsäuren, its salts and esters
10/26/2000CA2388545A1 Method for treatment of an aqueous flux by electropulsation of a field parallel to the flow, pulsation chamber and uses thereof
10/26/2000CA2371363A1 Antifungal agents isolated from pseudomonas syringae
10/26/2000CA2370659A1 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
10/26/2000CA2370239A1 Pseudomycin production by pseudomonas syringae
10/26/2000CA2369136A1 Pseudomycin natural products
10/26/2000CA2368029A1 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof
10/25/2000EP1046652A1 Method for quantitating denatured ldls
10/25/2000EP1046402A1 Aged skin equivalent, methods of preparation and uses thereof
10/25/2000EP1046400A1 Methods and compositions for treating human cells
10/25/2000EP1045920A1 Nucleotide expression systems with reduced immunogenicity for use in gene therapy
10/25/2000EP1045916A1 Enzymatic conversion of gdp-mannose to gdp-fucose
10/25/2000EP0852580B1 Method of producing dihydroxypyrimidine derivatives
10/25/2000EP0750626B1 Corpuscles of stannius protein, stanniocalcin
10/25/2000CN1271018A Process for producing L-glutamic acid
10/25/2000CN1270962A Improved method for preparing DNA from blooc serum and plasma
10/24/2000US6137007 Enantiomer compositions of (1R,4S)-1-butyrylamino-4-(hydroxymethyl)-2-cyclopentene
10/24/2000US6136989 Adding acetone to paclitaxel extract to form acetone mixture; contacting acetone mixture with aqueous solvent to form precipitate; recovering precipitate
10/24/2000US6136787 Interleukin 1β protease and interleukin 1β protease inhibitors
10/24/2000US6136593 Device for the removal of toxins from blood
10/24/2000US6136584 Joining polypeptide; for the development of and screening of therapy agents for autoimmune diseases
10/24/2000US6136583 Amidase
10/24/2000US6136581 Kinase genes and uses
10/24/2000US6136579 Isolating enzymatic protein; infecting a cell culture with pox viral vector, recovering enzymatic protein from lysis products
10/24/2000US6136578 Storage-stable liquid formulation comprising a laccase
10/24/2000US6136576 Method for the recombinant production of 1,3-propanediol
10/24/2000US6136572 Recombinant KAT enzyme and process for its preparation
10/24/2000US6136571 Method of producing saccharide preparations
10/24/2000US6136570 Method for producing RNA viruses from cDNA
10/24/2000US6136565 Methods of reducing the levels of protoporphyrin IX in recombinant hemoglobin preparations
10/24/2000US6136563 With defined substitutions for enhanced affinity for its receptor
10/24/2000US6136562 Synthetic dna which encodes a peptide having a defined amino acid sequence; for recombinant production of the peptide for use in cattle; veterinary medicine
10/24/2000US6136556 TCTS response regulator
10/24/2000US6136553 Computer based method for identifying amino acid sites which affect stability of the target protein
10/24/2000US6136544 Amino acid sequence of unedited form of human excitatory amino acid 4 receptor subunit; for drug screening
10/24/2000US6136534 Methods for sensitive detection of reverse transcriptase
10/24/2000US6136528 Multiple sclerosis virus
10/24/2000US6136527 Polypeptides derived from proteins of the hepatitis C virus, test kits containing these polypeptides and vaccines against infections of hepatitis C viruses
10/24/2000CA2147541C Preparation process of a natural protein sweetener
10/24/2000CA2065439C Expression of herbicide metobolizing cytochromes p450
10/24/2000CA2061569C Improved activation of recombinant proteins
10/24/2000CA2047702C Serpin resistant chymotrypsin superfamily proteases particularly pai-1 resistant t-pa, complementary inhibitor mutants; compositions; genes; expression
10/24/2000CA2035142C Stabilized cultures of microorganisms
10/24/2000CA1341124C Genetic engineering process for the preparation of hirudins, and means for carrying out this process
10/20/2000CA2306355A1 Methods and compositions for treating human cells
10/19/2000WO2000061781A1 Cyclic gmp dependent protein kinase as a chemotherapeutic target for antiprotozoal agents
10/19/2000WO2000061777A1 Process for the preparation of prostaglandin precursors
10/19/2000WO2000061769A1 ALKALINE PROTEASE VapK SUITABLE FOR LAUNDRY DETERGENT, vapk GENE, RECOMBINANT EXPRESSION VECTOR, AND TRANSFORMED MICROORGANISMS
10/19/2000WO2000061767A1 Extracellular protease from $i(acremonium chrysogenum) with cpc-acetyl hydrolase activity and its utilization in the synthesis of deacetylated derivatives of cephalosporin c and inactivation of the gene for increasing production of cephalosporin
10/19/2000WO2000061762A1 RECOMBINANT TOXIN A/TOXIN B VACCINE AGAINST $i(CLOSTRIDIUM DIFFICILE)
10/19/2000WO2000061751A1 REAGENTS AND METHODS FOR IDENTIFYING AND MODULATING EXPRESSION OF GENES REGULATED BY p21
10/19/2000WO2000061748A1 48 human secreted proteins
10/19/2000WO2000061746A1 13 transmembrane protein expressed in prostate cancer
10/19/2000WO2000061737A2 Production of attenuated negative stranded rna virus vaccines
10/19/2000WO2000061736A2 Recombinant and mutant marek's disease virus
10/19/2000WO2000061729A2 Regulation of the expression of transcriptional repressor genes using nucleic acid molecules
10/19/2000WO2000061727A2 Production of pancreatic procarboxy-peptidase b, isoforms and muteins thereof, and their use
10/19/2000WO2000061726A1 Composition for the preservation of infectious recombinant adenoviruses
10/19/2000WO2000061723A1 L-amino acid-producing bacteria and process for producing l-amino acid
10/19/2000WO2000061722A1 Process for the production of yeast biomass comprising functionally deleted $i(hxk2) genes
10/19/2000WO2000061721A1 Method for obtaining $i(a. niger) cultures and their uses for producing ferulic acid and vanillic acid
10/19/2000WO2000061611A2 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
10/19/2000WO2000061606A1 Novel human voltage-gated potassium channel
10/19/2000WO2000061591A1 Plant activator, process for producing the same, activation method, activity promoter and method for applying the promoter
10/19/2000WO2000061190A2 Treatment of intracellular infection
10/19/2000WO2000061156A2 Methods of treating schizophrenia
10/19/2000WO2000060947A1 Novel protective cultures and use thereof for preserving foodstuffs
10/19/2000WO2000031279A3 Producing antimicrobial cationic peptides as fusion proteins
10/19/2000WO2000029551A3 Cells, culture methods, and their use in autologous transplantation therapy
10/19/2000WO2000012720A8 Elongase genes and uses thereof
10/19/2000DE19917715A1 Neuartige Schutzkulturen und deren Verwendung bei der Konservierung von Lebensmitteln Novel protective cultures and their use in the preservation of food
10/19/2000DE19915938A1 Herstellung von pankreatischer Procarboxypeptidase B, Isoformen und Muteinen davon und ihre Verwendung Production of pancreatic procarboxypeptidase B isoforms and its muteins and their use
10/19/2000DE19915057A1 Monoklonale Antikörper gegen das humane Mcm3 Protein, Verfahren zu ihrer Herstellung und ihre Verwendung Monoclonal antibodies to human protein Mcm3, processes for their preparation and their use
10/19/2000CA2372078A1 Treatment of intracellular infection
10/19/2000CA2370114A1 Method for obtaining a. niger cultures and their uses for producing ferulic acid and vanillic acid